EFI
VRTX icon

EHP Funds Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

EHP Funds Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,600
Closed -$669K – 145
2024
Q1 		$669K Sell
1,600
-200
-11% -$84.5K 0.27% 40
2023
Q4 		$732K Sell
1,800
-500
-22% -$185K 0.27% 56
2023
Q3 		$800K Buy
2,300
+200
+10% +$69.9K 0.37% 75
2023
Q2 		$739K Sell
2,100
-1,120
-35% -$377K 0.18% 100
2023
Q1 		$1.01M Sell
3,220
-650
-17% -$195K 0.2% 99
2022
Q4 		$1.12M Buy
3,870
+40
+1% +$12.2K 0.21% 101
2022
Q3 		$1.11M Buy
+3,830
New +$1.1M 0.22% 106

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

EHP Funds Inc's VRTX Position: Q2 2024 in Review

EHP Funds Inc sold out of Vertex Pharmaceuticals (VRTX) in Q2 2024, closing a stake of 1,600 shares — an estimated $669K sold.

EHP Funds Inc first reported a position in VRTX in Q3 2022 and held it in 7 quarters. The position peaked at $1.12M in Q4 2022. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

  • EHP Funds Inc reported no remaining Vertex Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • EHP Funds Inc sold 1,600 Vertex Pharmaceuticals shares in Q2 2024, an estimated $669K.
  • EHP Funds Inc first reported a position in Vertex Pharmaceuticals in Q3 2022 and held it in 7 quarters.
  • EHP Funds Inc's Vertex Pharmaceuticals position peaked at $1.12M in Q4 2022.
  • 1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on EHP Funds Inc's 13F filing for Q2 2024, filed 14 Aug 2024.